Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Small molecule-based therapy for Visceral pain: TWIST1 decreases visceral pain in patients with Irritable Bowel Syndrome via up regulation of its target gene, 15/February/2015, 21.27, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that TWIST1, by increasing the expression of its target gene, it may decrease visceral pain in patients with Irritable Bowel Syndrome. Thus, pharmacological formulations encompassing “TWIST1 activators“ may be used to treat visceral pain.
Amount: $ 500*
Undisclosed information: How TWIST1 decreases visceral pain
Courtesy: When you cite drop us a line at firstname.lastname@example.org